Zynex, Inc., a medical technology company, designs, manufactures, and markets electrotherapy medical devices used for pain management and rehabilitation. Its products include NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation device; NeuroMove, an electromyography triggered electrical stimulation device; and InWave, an electrical stimulation product for the treatment of female urinary incontinence. The company also distributes private labeled products, such as electrodes for the delivery of electrical current to the body; batteries for use in electrotherapy products; Comfortrac for cervical traction; JetStream for hot/cold therapy; and LSO Back Braces for lumbar support. In addition, it develops non-invasive blood volume monitors for use in hospitals and surgery centers. The company offers its products for pain management and control; and stroke and spinal cord injury rehabilitation. It sells its products through direct and independent sales representatives primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
Industry, Sector and Symbol
Stock Exchange OTCMKTS
Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:ZYXI
CUSIPN/A
Phone303-703-4906
Debt
Debt-to-Equity RatioN/A
Current Ratio3.14
Quick Ratio2.98
Price-To-Earnings
Trailing P/E Ratio13.14
Forward P/E Ratio10.32
P/E GrowthN/A
Sales & Book Value
Annual Sales$23.43 million
Price / Sales4.10
Cash Flow$0.2474 per share
Price / Cash11.68
Book Value$0.23 per share
Price / Book12.57
Profitability
EPS (Most Recent Fiscal Year)$0.22
Net Income$7.36 million
Net Margins33.49%
Return on Equity205.15%
Return on Assets110.67%
Miscellaneous
Employees109
Outstanding Shares33,230,000
Market Cap$96.38 million
Zynex Inc. common stock (OTCMKTS:ZYXI) Frequently Asked Questions
What is Zynex Inc. common stock's stock symbol?
Zynex Inc. common stock trades on the OTCMKTS under the ticker symbol "ZYXI."
How were Zynex Inc. common stock's earnings last quarter?
Zynex Inc. common stock (OTCMKTS:ZYXI) posted its quarterly earnings results on Thursday, August, 2nd. The company reported $0.07 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.06 by $0.01. The business had revenue of $7.57 million for the quarter, compared to analysts' expectations of $7.75 million. Zynex Inc. common stock had a net margin of 33.49% and a return on equity of 205.15%. View Zynex Inc. common stock's Earnings History.
What is the consensus analysts' recommendation for Zynex Inc. common stock?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zynex Inc. common stock in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Zynex Inc. common stock.
Who are some of Zynex Inc. common stock's key competitors?
Some companies that are related to Zynex Inc. common stock include electroCore (ECOR), BioLife Solutions (BLFS), Rockwell Medical (RMTI), Vision Sciences (CGNT), Helius Medical Technologies (HSDT), Fonar (FONR), Semler Scientific (SMLR), Second Sight Medical Products (EYES), IRIDEX (IRIX), BioSig Technologies (BSGM), Edap Tms (EDAP), Viveve Medical (VIVE), Soleno Therapeutics (SLNO), Stereotaxis (STXS) and Digirad (DRAD).
Who are Zynex Inc. common stock's key executives?
Zynex Inc. common stock's management team includes the folowing people:
- Mr. Thomas Sandgaard, Founder, Pres, CEO & Chairman (Age 59)
- Mr. Daniel J. Moorhead, Chief Financial Officer (Age 46)
- Mr. David B. Mogill, VP of Operations
- Mr. Robert Bird, VP of Marketing
- Mr. Steve Siefring, Director of Bus. Devel.
Has Zynex Inc. common stock been receiving favorable news coverage?
Media stories about ZYXI stock have trended somewhat positive on Tuesday, according to Accern. Accern scores the sentiment of press coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Zynex Inc. common stock earned a media and rumor sentiment score of 0.25 on Accern's scale. They also assigned news stories about the company an impact score of 45.43 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next few days. View Recent Headlines for Zynex Inc. common stock.
How do I buy shares of Zynex Inc. common stock?
Shares of ZYXI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Zynex Inc. common stock's stock price today?
One share of ZYXI stock can currently be purchased for approximately $2.89.
How big of a company is Zynex Inc. common stock?
Zynex Inc. common stock has a market capitalization of $96.38 million and generates $23.43 million in revenue each year. The company earns $7.36 million in net income (profit) each year or $0.22 on an earnings per share basis. Zynex Inc. common stock employs 109 workers across the globe.
How can I contact Zynex Inc. common stock?
Zynex Inc. common stock's mailing address is 9555 MAROON CIRCLE, ENGLEWOOD CO, 80112. The company can be reached via phone at 303-703-4906 or via email at [email protected]
MarketBeat Community Rating for Zynex Inc. common stock (OTCMKTS ZYXI)
MarketBeat's community ratings are surveys of what our community members think about Zynex Inc. common stock and other stocks. Vote "Outperform" if you believe ZYXI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ZYXI will underperform the S&P 500 over the long term. You may vote once every thirty days.
